T1	Premise 1042 1136	there were no statistically significant differences in HRQOL between the two treatment groups.
T2	Premise 1137 1227	In both groups, selected aspects of HRQOL were impaired over time, with increased fatigue,
T3	Premise 1228 1355	although some clinically significant improvements in emotional functioning were seen, as well as a reduction in pain over time.
T4	Claim 1356 1428	Overall, global quality of life was maintained in both treatment groups.
T5	Claim 1429 1625	This information is important when advising women patients of the expected HRQOL consequences of treatment regimens and should help clinicians and their patients make informed treatment decisions.
R1	Partial-Attack Arg1:T3 Arg2:T2	
R2	Attack Arg1:T2 Arg2:T4	
R3	Support Arg1:T1 Arg2:T4	
